Buprenorphine Deaths Did Not Increase Despite Wider Access During Pandemic, Study Shows
January 20, 2023
(STAT News) – The onset of the Covid-19 pandemic led to a sea change in addiction medicine — in particular, increased access to buprenorphine, a drug commonly used to treat opioid use disorder. Now, new data show that despite the medication’s wider availability, deaths involving buprenorphine still constitute a small fraction of overall drug mortality. (Read More)